The importance of gene expression programs cannot be understated as they form the backbone of cellular functions and activities. At its core, the RNA lifecycle is vital in controlling where and when proteins are synthesized. The newly introduced methodology cleverly integrates several existing technologies to provide a nuanced look at the molecular dance of RNA and its implications for cellular behavior, enabling scientists to visualize and quantify the dynamic interplay of RNAs in their native environments.

One of the standout features of this protocol is its ability to utilize antibody-based protein co-mapping along with advanced sequencing techniques. By selectively converting targeted RNAs, ribosome-bound mRNAs, and metabolically labeled RNAs into DNA amplicons, researchers can generate gene-unique barcodes that facilitate in situ sequencing. This process is harnessed within a confocal microscope setting, offering a powerful lens through which the spatial distribution and temporal changes of RNA species can be observed.

What sets the STARmap PLUS, RIBOmap, and TEMPOmap approach apart from other existing methods is its extraordinary analytical capacity. While traditional techniques may fall short in terms of spatial and temporal resolution, this integrated toolkit enables the simultaneous tracking of thousands of RNA species in intact cells and tissues. This level of multiplexing not only enhances the precision of the data but also enriches the overall understanding of the transcriptomic landscape within various cellular contexts.

The experimental protocols associated with these methodologies are accessible for laboratories already familiar with RNA handling and possessing confocal microscopy tools. The preparation of the amplicon library is designed to be efficient, taking only two to three days followed by variable sequencing times based on the sample size and the number of target genes. This streamlined workflow empowers scientists to gather substantial amounts of data quickly, expediting the drive towards deeper biological discoveries.

After obtaining the spatially resolved single-cell profiles, researchers can embark on various downstream analyses. Cell type classification, cell cycle identification, and the determination of RNA lifecycle kinetic parameters are just a few of the analyses made possible by the rich datasets generated through this protocol. Comprehensive computational analysis, guided by established tutorials, enables researchers to draw meaningful insights from their gathered data, further illuminating the complexities of RNA dynamics.

Additionally, the STARmap PLUS, RIBOmap, and TEMPOmap techniques have profound implications not only for basic research but also for applications in disease studies and therapeutic innovations. A clearer understanding of RNA dynamics within heterogeneous populations could pave the way for novel therapeutic strategies, particularly in complex diseases such as cancer, where localized gene expression patterns can greatly influence treatment efficacy and disease progression.

As more laboratories adopt these advanced methodologies, the collective knowledge surrounding spatial transcriptomics is poised to expand exponentially. Innovations within this field will propel forward our understanding of how genes are regulated and expressed in health and disease. Researchers are encouraged to delve into this spatial omics toolkit, allowing them to unlock new dimensions of biology that have remained elusive until now.

The future of cellular studies is rapidly evolving, and this integrated protocol serves as a beacon for researchers. By employing STARmap PLUS, RIBOmap, and TEMPOmap, scientists can create detailed maps of transcriptomic activity, which will ultimately advance our grasp of molecular biology on many levels. This fusion of technology and biology heralds a new era in understanding the intricate relationships that govern life at the cellular level.

In conclusion, advancements in imaging-based multiplexed in situ profiling are set to revolutionize the way we investigate the RNA lifecycle. As researchers leverage these cutting-edge techniques, they are likely to uncover nuanced insights into the spatiotemporal dynamics of RNA which could reshape our understanding of cellular functions and diversity. This work not only signifies a technical marvel but also stands as a testament to what can be achieved when innovation in methodology meets the curiosity of scientific inquiry.

Ultimately, the integration of advanced protocols in visualizing and quantifying RNA’s spatial-temporal dynamics encapsulates the essence of modern biology. The STARmap PLUS, RIBOmap, and TEMPOmap methodologies exemplify the ambitious strides being made in the field, propelling both basic and translational research to new heights in understanding the complexities of life itself.

Researchers and institutions engaged in cellular biology are hereby invited to embrace this toolkit, not merely as a collection of techniques, but as a transformative lens that reconfigures how we observe and understand the intricacies of gene expression. The potential implications of this technology, both for fundamental science and for clinical applications, are vast and ripe for exploration.

Subject of Research: RNA life cycle and spatial transcriptomics

Article Title: Spatially resolved in situ profiling of mRNA life cycle at transcriptome scale in intact cells and tissues using STARmap PLUS, RIBOmap and TEMPOmap

Article References:

Ren, J., Zeng, H., Huang, J. et al. Spatially resolved in situ profiling of mRNA life cycle at transcriptome scale in intact cells and tissues using STARmap PLUS, RIBOmap and TEMPOmap. Nat Protoc (2025). https://doi.org/10.1038/s41596-025-01248-3

Image Credits: AI Generated

DOI:

Keywords: Spatial transcriptomics, RNA lifecycle, gene expression, confocal microscopy, STARmap, RIBOmap, TEMPOmap, multiplexing, single-cell analysis, cellular biology.

This disconnect between transcript abundance and protein levels stems from numerous regulatory layers operating post-transcriptionally. Cellular mechanisms controlling mRNA stability, translational efficiency, and protein degradation collectively dictate the proteome landscape within cells. These processes are highly context-dependent and vary throughout different stages of cellular differentiation and function. Consequently, relying solely on RNA measurements provides an incomplete picture, especially when investigating lineage commitment and cellular maturation pathways.

Addressing this limitation, a collaborative research team spanning the Finsen Laboratory at Rigshospitalet, the Biotech Research and Innovation Centre (BRIC) at the University of Copenhagen, the Technical University of Denmark (DTU), and Helmholtz Zentrum München has pioneered the application of single-cell proteomics by mass spectrometry (scp-MS) in a biologically relevant human organ system. Specifically, their study focuses on early human blood cell differentiation, transitioning from multipotent stem cells to mature blood cell types, charting protein-level changes with unprecedented resolution.

Single-cell proteomics by mass spectrometry breaks away from traditional nucleic acid-centric approaches by directly quantifying proteins—the functional effectors of cellular behavior. This technique, still in its infancy, has overcome enormous technical challenges including exceedingly low protein quantities present in single cells, requiring ultra-sensitive instrumentation and innovative sample preparation protocols. The researchers successfully employed scp-MS to detect thousands of proteins per cell, sufficiently covering the dynamic proteome landscape within developing hematopoietic lineages.

A critical breakthrough unveiled by this study is the nuanced divergence between mRNA and protein profiles at different stages of differentiation. While more differentiated blood cells displayed strong correlations between transcript and protein levels, stem and immature progenitor cells revealed significant discrepancies. This disparity highlights regulatory phenomena unique to early differentiation stages involving rapid mRNA turnover, variable translation rates, or differential protein stability — insights previously obscured by RNA-only analyses.

By integrating scRNA-seq data with comprehensive single-cell protein quantification, the team constructed a dynamic model capturing the full lifecycle of gene expression—from mRNA synthesis and decay to protein translation and degradation. This integrative approach reveals multilayered regulatory controls shaping cell fate decisions, emphasizing how protein-level measurements illuminate biological processes invisible to transcriptomics alone.

Further functional investigations into proteins that declined in abundance during differentiation despite stable mRNA levels revealed essential roles in maintaining stem cell populations. Through gene knock-out experiments, researchers demonstrated that depletion of these proteins precipitates a reduction in stem cell numbers, thereby impairing hematopoiesis. These findings underscore the indispensability of protein-level regulation in sustaining adult stem cell niches and ensuring adequate blood cell replenishment.

The implications of this research transcend basic biology, offering promising avenues for medical advancements. The ability to directly measure proteome dynamics at single-cell resolution in primary human tissues opens new frontiers for understanding developmental disorders, malignancies such as leukemia, and regenerative processes. It provides a powerful platform for identifying novel therapeutic targets that would be otherwise concealed by RNA-level studies.

Co-senior author Erwin Schoof of DTU emphasizes the transformative potential of this technology: “Mass spectrometry-driven protein profiling delivers a layer of biological information paramount to decoding how individual cells navigate their fates. What once seemed like science fiction—measuring thousands of proteins in single human stem cells—is now reality, propelling single-cell biology into an era of unprecedented clarity.”

Simultaneously, the study exemplifies how advanced technological development and interdisciplinary collaboration empower breakthroughs. By uniting expertise in proteomics, computational biology, and stem cell research, the consortium realized a holistic understanding of hematopoietic differentiation. Computational health sciences, led by thought leaders such as Fabian Theis at Helmholtz Munich, played a pivotal role in modeling and interpreting complex, multidimensional datasets.

The researchers are hopeful that this integrated proteomic-transcriptomic methodology will soon become routine in studying other organ systems and disease states. Its adoption could revolutionize diagnostics, enabling clinicians to detect hidden dysregulations at the protein level before clinical symptoms manifest, thereby facilitating earlier interventions.

Their upcoming publication in Science marks a seminal moment in single-cell biology, evidencing how combining cutting-edge mass spectrometry with sophisticated computational frameworks reveals previously inaccessible layers of biological regulation. Just as telescopes expanded humanity’s knowledge of the cosmos, single-cell proteomics is expanding our vision into the intricate machinery underpinning life itself.

In conclusion, by capturing the dynamic interplay between mRNA and protein synthesis and degradation at single-cell resolution, this work ushers in a paradigm shift. It challenges the dominance of RNA-based methods, establishing protein-level measurements as essential for uncovering the full spectrum of cellular identity, function, and fate-determining mechanisms. This holistic perspective is critical for deciphering complex biological systems and developing innovative therapeutic strategies for some of the most pressing human diseases.

Subject of Research: Early human blood cell differentiation analyzed via single-cell proteomics and transcriptomics
Article Title: Mapping early human blood cell differentiation using single-cell proteomics and transcriptomics
News Publication Date: 21-Aug-2025
Web References: 10.1126/science.adr8785
References: Publication forthcoming in Science journal
Keywords: Single-cell proteomics, Mass spectrometry, Hematopoiesis, Blood cell differentiation, Stem cells, Transcriptomics, scRNA-seq, Protein expression, Gene regulation, Stem cell niche, Systems biology, Translational regulation

At the heart of their work lies the creation of an expansive, transcriptome-wide atlas of translation efficiency (TE) measurements. This vast resource integrates data from over 3,800 ribosomal profiling experiments across more than 140 distinct human and mouse cell types. Ribosome profiling, a cutting-edge technique that captures snapshots of ribosomes actively engaged in protein synthesis, provides a high-resolution map of translational activity. By synthesizing this wealth of data, the researchers have established an encompassing platform that captures the multifaceted dynamics of how mRNA sequences influence their own translation rates across mammalian tissues.

The question of how the intrinsic features encoded in mRNA sequences control translation has long been a challenge due to the complexity and variability inherent in cellular systems. Traditional approaches tended to focus narrowly on the 5′ untranslated region (5′ UTR)—the segment of mRNA upstream of the coding sequence—often examining its sequence motifs or secondary structures. Although informative, these models have been unable to consistently predict translation efficiency across diverse cellular contexts, leaving a fragmented understanding of translational regulation.

To overcome these limitations, the team developed RiboNN, a state-of-the-art multitask deep convolutional neural network uniquely engineered to parse the intricate language of mRNA sequences. Unlike prior models that considered only the 5′ UTR, RiboNN integrates spatial positional data of low-level dinucleotide and trinucleotide features, including codon usage patterns scattered throughout the mRNA. By encoding the subtle interplay between these sequence elements and their locations, the neural network captures mechanistic insights such as how ribosomal processivity—the ability of ribosomes to traverse mRNA without premature dissociation—and tRNA abundance shape the translational landscape.

The architecture of RiboNN is a testament to advances in machine learning tailored for biological sequences. By adopting convolutional layers, the model identifies local sequence motifs and higher-order combinations, while its multitask framework facilitates predictions across hundreds of cell types simultaneously. This allows it not only to generalize translational patterns across species and cell types but also to discern cell-specific nuances in translational control mechanisms. The authors further benchmarked RiboNN against classical machine learning models, demonstrating its superior ability to predict translation efficiency with remarkable precision.

One of the most striking applications of RiboNN is its capacity to predict the translational behavior of therapeutic RNAs that harbor chemical base modifications. These modifications—vital to the development of novel RNA-based medicines such as mRNA vaccines—can alter how the cellular machinery interprets and translates mRNA sequences. RiboNN successfully models these effects at a sequence-level resolution, offering valuable insights into how modified nucleotides impact translation, a feat that holds significant implications for optimizing the design of next-generation RNA therapeutics.

Beyond therapeutic contexts, the model also sheds light on evolutionary forces shaping human mRNA. Through comparative analyses of 5′ UTR sequences, RiboNN provides evidence for evolutionary selection pressures that have sculpted translational control elements, suggesting that efficient translation has been a driving factor in shaping regulatory sequences. This evolutionary perspective highlights the intertwined nature of molecular function and genetic evolution, framing translational efficiency as a key selective trait in mammalian biology.

Furthermore, the study reveals a fascinating interconnectedness among mRNA translation, stability, and subcellular localization—processes previously studied in isolation. By integrating these facets, RiboNN uncovers a common “language” that governs mRNA regulatory control. The model suggests that sequence features influencing translation are often co-regulated with elements determining an mRNA’s lifespan and its transport within the cell, emphasizing the coordinated regulation of gene expression at multiple layers.

The implications of these findings are profound. With a predictive tool like RiboNN, researchers can now systematically dissect the rules of translational control embedded within mRNA sequences. This empowers synthetic biologists to engineer RNAs with tailor-made translational profiles, potentially enabling precise control over protein expression in therapeutic settings. It also equips geneticists with a powerful lens to interpret how natural variants in non-coding regions may affect cellular function through changes in translation efficiency, informing disease models and personalized medicine approaches.

The research also offers a roadmap for integrating big data and deep learning to resolve longstanding biological questions. By leveraging thousands of ribosomal profiling datasets, combined with advanced neural network architectures, the study exemplifies how computational innovation can drive biological discovery. This cross-disciplinary approach may serve as a prototype for unraveling other complex regulatory networks essential to life.

Critically, the comprehensive nature of the TE atlas generated in this study promises to be a valuable resource for the scientific community. Beyond its immediate applications, it provides a foundational dataset for developing additional predictive tools and for validating hypotheses about translational regulation. The availability of such a large-scale dataset, covering numerous cell types and species, ensures that future research can build on this base to deepen our understanding of protein synthesis regulation.

In the broader scope, this study underscores the intricate choreography of molecular components orchestrating gene expression. Translation—long viewed simply as the final step in converting genetic information into protein—emerges here as a highly regulated and context-dependent process dictated by nuanced sequence features and cellular environments. The discovery of a “common language” of mRNA control refines our perception of gene regulation, moving from deterministic scripts to dynamic, contextually responsive codes.

Looking ahead, RiboNN’s approach could be expanded to cover additional layers of translational regulation, such as the impact of RNA-binding proteins, mRNA modifications beyond the canonical bases, and feedback loops involving protein synthesis and degradation. The adaptability of deep learning models to incorporate diverse data types means the future of predictive molecular biology is bright, with the promise of ever more accurate models of cellular processes.

Moreover, the integration of these findings into clinical and biotechnological applications stands to accelerate the development of RNA-based therapeutics with enhanced efficacy and reduced side effects. By understanding how sequence features and positional information govern translation, the design of more stable, efficiently translated mRNAs tailored to specific cell types could become routine, paving the way towards personalized RNA medicines.

In conclusion, this landmark study by Zheng and colleagues represents a significant leap forward in decoding how mRNA sequences dictate their translation efficiency within mammalian cells. Through the synthesis of massive ribosome profiling datasets and the innovative application of deep convolutional neural networks, it has uncovered fundamental principles guiding translational control. The introduction of RiboNN as both a predictive tool and a conceptual framework provides the molecular biology community with a powerful new resource to explore, manipulate, and ultimately harness the complex language of mRNA translation.

Subject of Research: Predictive modeling of translation efficiency in mammalian mRNA sequences using deep learning and ribosomal profiling data.

Article Title: Predicting the translation efficiency of messenger RNA in mammalian cells.

Article References:
Zheng, D., Persyn, L., Wang, J. et al. Predicting the translation efficiency of messenger RNA in mammalian cells.
Nat Biotechnol (2025). https://doi.org/10.1038/s41587-025-02712-x

Image Credits: AI Generated

Translation is the final step of gene expression, generally initiated via the recognition of the 5′ cap structure on mRNA. However, recent studies spearheaded by the “Immunobiochemistry” research group highlight an alternative route for initiation—through structures known as internal ribosomal entry sites (IRESes). These specialized RNA sequences have garnered attention for their ability to facilitate the initiation of translation independently from conventional pathways, particularly in the context of viral infections. For instance, viruses such as hepatitis C and poliovirus exploit IRES elements to hijack the host’s translational machinery, thereby ensuring the synthesis of viral proteins without the need for typical initiation factors.

IRESes are defined as uniquely folded RNA structures located within mRNA strands, often identified within viral genomes. However, their presence has also been increasingly documented in eukaryotic cells, organisms characterized by their defined nuclei. The identification of IRESes in eukaryotes questions the traditional understanding of translational regulation and suggests a sophisticated level of control over protein production. As noted by Philipp Koch, the lead author of a recent study from the Leppek group at UKB, the characterization of these IRESes, especially from eukaryotic mRNAs, remains a significant challenge due to technical limitations associated with existing methodologies.

One of the notable hurdles in IRES research has been the accurate and reliable characterization of these elements from various mRNAs. Previous attempts to study IRESes have been hindered by artifacts that arise during experimental procedures, making it difficult to ascertain their true nature and functionality. To overcome these challenges, researchers in Bonn have been compiling an array of innovative techniques aimed at providing robust characterization of IRESes. Among these methods, the use of circular RNA reporters stands out as a groundbreaking approach. This technique facilitates the validation of IRES-mediated translation activity, effectively confirming the role of these structures in protein synthesis.

Additionally, the researchers have implemented quantitative staining techniques to examine individual mRNAs within mouse embryo tissues. This allows for a nuanced analysis of the translation rates of specific IRES-containing mRNAs, enhancing the understanding of how these elements govern gene expression in vivo. The establishment of such a comprehensive toolkit marks a turning point in IRES research. It provides a systematic and reliable framework for future studies, establishing a new gold standard for the exploration and characterization of these intriguing RNA elements.

The implications of strong IRES elements are not just theoretical; they have significant relevance in the realms of synthetic biology and emerging mRNA therapeutic applications. Prof. Leppek emphasizes the potential these IRES structures hold for enhancing the efficiency of mRNA-based therapies, particularly as the field of synthetic biology seeks to produce tailored proteins for therapeutic use. The robustness of the methods developed by the Bonn researchers not only enhances the understanding of fundamental biological processes but also paves the way for practical applications in medicine.

The funding for this innovative research has been generously provided by the German Research Foundation (DFG) as part of the ImmunoSensation2 Cluster of Excellence. Additionally, the University of Bonn has supported this work through the “TRA: Life and Health Research Prize 2024” and the university-wide “Strengthening the Equal Opportunity Process (STEP)” program. As a testament to the collaborative nature of scientific advancement, the UKB and the University of Bonn have secured a patent in conjunction with Stanford University, focusing on the development of effective non-viral IRES sequences aimed at enhancing circular RNA translation for therapeutic and immunogenic protein production.

In summary, the recent investigations into ribosomal interactions with IRESes reveal a complex layer of regulation in gene expression that extends beyond traditional paradigms. These findings not only challenge the established concepts of translational control in eukaryotic systems but also open new avenues for practical applications in vaccine development and tailored therapies. As research progresses, the potential of IRESes to shape the future of genetic engineering and mRNA therapeutics cannot be overstated.

The exploration of ribosomal dynamics and IRES functionality necessitates a collaborative drive from multiple disciplines, each contributing to a deeper understanding of cellular machinery. It is through continual advancements in molecular biology techniques that researchers can unravel the intricacies of translation control, ultimately leading to novel therapeutic strategies and improved health outcomes. As the field moves forward, the significance of these findings will undoubtedly foster exciting developments in molecular research and biotechnology.

Collaborative efforts and interdisciplinary approaches will likely yield further insights into the molecular mechanisms at play, primarily how viruses manipulate host cellular machinery. Understanding these interactions at a deeper level will not only augment the basic science of molecular biology but could also translate into significant clinical advancements, particularly in combating viral diseases that utilize similar mechanisms for proliferation. Enhanced comprehension of IRES elements will therefore inform future research directions and therapeutic interventions aimed at mitigating the impacts of viral infections on human health.

With the robust methodologies being established by the research group at UKB, there exists a promising horizon for the ongoing study of IRESes and their roles within the broader context of molecular biology and translational medicine. As these researchers continue to innovate and refine their techniques, the door opens wider for significant contributions to our understanding of gene expression regulation, with implications that could resonate across various fields, from fundamental research to clinical application.

Ultimately, the pioneering work laid out by Prof. Leppek and her team represents a dynamic intersection of scientific inquiry, innovative methodology, and potential therapeutic ramifications, showcasing the enduring relevance of molecular research in addressing fundamental questions about the biology of life and disease. The collective effort to decode the functionalities of ribosomes and their interactions with IRESs not only enhances the knowledge base of cellular biology but also creates a roadmap for future explorations.

Amidst the challenges posed by the evolving landscape of molecular research, the insights garnered from the study of ribosomes and IRESes will remain at the forefront of scientific exploration. By illuminating the complexities of translation regulation, researchers are better equipped to tackle pressing biomedical challenges and to harness the power of molecular machinery for transformative breakthroughs in health and disease management.

Subject of Research: The role of ribosomal interactions with internal ribosomal entry sites (IRESes) in gene expression regulation.
Article Title: Insights into Ribosomes: Unveiling the Role of Internal Ribosomal Entry Sites in Gene Expression
News Publication Date: October 2023
Web References:
References:
Image Credits:
Keywords: Ribosomes, mRNA translation, internal ribosomal entry sites, gene expression regulation, synthetic biology, viral mechanisms, translational control.